BDTX icon

Black Diamond Therapeutics
BDTX

Overview Fund Activity

88 hedge funds and large institutions have $200M invested in Black Diamond Therapeutics in 2024 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 24 increasing their positions, 22 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
88
Holders Change
+12
Holders Change %
+15.79%
% of All Funds
1.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
24
Reduced
22
Closed
14
Calls
$243K
Puts
$51K
Net Calls
+$192K
Net Calls Change
+$35K

Top Buyers

1
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$14.2M
2
LCM
Laurion Capital Management
New York
+$4.45M
3
Millennium Management
Millennium Management
New York
+$2.15M
4
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
+$1.59M
5
Goldman Sachs
Goldman Sachs
New York
+$1.46M

Top Sellers

1
Verition Fund Management
Verition Fund Management
Connecticut
-$6.21M
2
AG
Artal Group
Luxembourg
-$5.07M
3
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$4.12M
4
IC
Ikarian Capital
Texas
-$1.56M
5
CS
Candriam SCA
Luxembourg
-$1.52M
Name Holding Trade Value Shares
Change 		Shares
Change %
Fidelity Investments
101
Fidelity Investments
Massachusetts
– -$6 -2 Closed
1 2 3 4
5